Related Experiment Videos
Loss of p14ARF expression in melanoma
Rafael Dobrowolski1, Rüdiger Hein, Reinhard Buettner
1Institute of Pathology, University of RWTH Aachen, Germany.
Archives of Dermatological Research
|March 6, 2002
Summary
The tumor suppressor p14ARF protein expression decreases as melanoma progresses from benign nevi to metastatic stages. This suggests p14ARF inactivation is crucial in melanoma development.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- p14ARF (alternative reading frame) is a tumor suppressor.
- Lack of p14ARF expression is observed in various carcinomas.
- p14ARF inactivation is implicated in cancer development.
Purpose of the Study:
- To investigate p14ARF gene and protein expression in melanomas.
- To determine the role of p14ARF in melanoma progression.
Main Methods:
- Screening of eight human melanoma cell lines and melanocytes using RT-PCR, sequencing, and immunoblotting.
- Immunohistochemical staining of 32 tissue samples (benign nevi, melanomas, melanoma metastases).
Main Results:
- All analyzed melanoma cell lines expressed wild-type p14ARF mRNA and protein.
- Immunohistochemistry revealed a correlation between melanoma progression and reduced p14ARF protein expression.
- Positive p14ARF staining was observed in 11/14 benign nevi, 3/12 melanomas, and 0/6 melanoma metastases.
Conclusions:
- A significant inverse correlation exists between p14ARF protein expression and melanocytic tumor progression.
- p14ARF protein levels decrease from benign nevi to metastatic melanoma.
- p14ARF inactivation is suggested to be important in melanoma development.